Bernard Ravina, Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR), sold 4,902 shares at $25.16 ($123K) on 2018-03-12, disclosed to the SEC on 2018-03-14.
Open-market sale of $123k VYGR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.16 | 2,451 | $62K | 50.0% |
| 2 | $25.16 | 2,451 | $62K | 50.0% |
| Total | $25.16 avg | 4,902 | $123K | 100% |
| Filing → |
| VYGR | SELL | 2018-01-12 | $119K | — | Filing → |
| VYGR | SELL | 2017-12-13 | $150K | — | Filing → |
| VYGR | SELL | 2017-11-13 | $146K | — | Filing → |